<?xml version="1.0" encoding="UTF-8"?>
<!DOCTYPE root>
<article xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xmlns:ali="http://www.niso.org/schemas/ali/1.0/" article-type="other" dtd-version="1.2" xml:lang="en"><front><journal-meta><journal-id journal-id-type="publisher-id">Russian Journal of Physiology</journal-id><journal-title-group><journal-title xml:lang="en">Russian Journal of Physiology</journal-title><trans-title-group xml:lang="ru"><trans-title>Российский физиологический журнал им. И.М. Сеченова</trans-title></trans-title-group></journal-title-group><issn publication-format="print">0869-8139</issn><issn publication-format="electronic">2658-655X</issn><publisher><publisher-name xml:lang="en">The Russian Academy of Sciences</publisher-name></publisher></journal-meta><article-meta><article-id pub-id-type="publisher-id">651582</article-id><article-id pub-id-type="doi">10.31857/S0869813923040039</article-id><article-id pub-id-type="edn">VIWGPC</article-id><article-categories><subj-group subj-group-type="toc-heading" xml:lang="en"><subject>EXPERIMENTAL ARTICLES</subject></subj-group><subj-group subj-group-type="toc-heading" xml:lang="ru"><subject>ЭКСПЕРИМЕНТАЛЬНЫЕ СТАТЬИ</subject></subj-group><subj-group subj-group-type="article-type"><subject></subject></subj-group></article-categories><title-group><article-title xml:lang="en">Research of the Expression of IL-13 Receptors and IL-13R Genes in the Bronch of Rats with Ovalbumin-Induced Bronchial Asthma</article-title><trans-title-group xml:lang="ru"><trans-title>Исследование экспрессии рецепторов к IL-13, генов IL-13R в бронхах крыс с овальбумин-индуцированной бронхиальной астмой</trans-title></trans-title-group></title-group><contrib-group><contrib contrib-type="author"><name-alternatives><name xml:lang="en"><surname>Blazhevich</surname><given-names>L. E.</given-names></name><name xml:lang="ru"><surname>Блажевич</surname><given-names>Л. Е.</given-names></name></name-alternatives><email>lyu15041988@yandex.ru</email><xref ref-type="aff" rid="aff1"/></contrib><contrib contrib-type="author"><name-alternatives><name xml:lang="en"><surname>Smirnova</surname><given-names>O. E.</given-names></name><name xml:lang="ru"><surname>Смирнова</surname><given-names>О. Е.</given-names></name></name-alternatives><email>lyu15041988@yandex.ru</email><xref ref-type="aff" rid="aff1"/></contrib><contrib contrib-type="author"><name-alternatives><name xml:lang="en"><surname>Kirilina</surname><given-names>V. M.</given-names></name><name xml:lang="ru"><surname>Кирилина</surname><given-names>В. М.</given-names></name></name-alternatives><email>lyu15041988@yandex.ru</email><xref ref-type="aff" rid="aff1"/></contrib><contrib contrib-type="author"><name-alternatives><name xml:lang="en"><surname>Maslyukov</surname><given-names>P. M.</given-names></name><name xml:lang="ru"><surname>Маслюков</surname><given-names>П. М.</given-names></name></name-alternatives><email>lyu15041988@yandex.ru</email><xref ref-type="aff" rid="aff2"/></contrib></contrib-group><aff-alternatives id="aff1"><aff><institution xml:lang="en">Petrozavodsk State University</institution></aff><aff><institution xml:lang="ru">Петрозаводский государственный университет, Республика Карелия</institution></aff></aff-alternatives><aff-alternatives id="aff2"><aff><institution xml:lang="en">Yaroslavl State Medical University of the Ministry of Healthcare of the Russian Federation</institution></aff><aff><institution xml:lang="ru">Ярославский государственный медицинский университет Министерства здравоохранения
Российской Федерации</institution></aff></aff-alternatives><pub-date date-type="pub" iso-8601-date="2023-04-01" publication-format="electronic"><day>01</day><month>04</month><year>2023</year></pub-date><volume>109</volume><issue>4</issue><fpage>530</fpage><lpage>544</lpage><history><date date-type="received" iso-8601-date="2025-02-01"><day>01</day><month>02</month><year>2025</year></date></history><permissions><copyright-statement xml:lang="en">Copyright ©; 2023, Л.Е. Блажевич, О.Е. Смирнова, В.М. Кирилина, П.М. Маслюков</copyright-statement><copyright-statement xml:lang="ru">Copyright ©; 2023, Л.Е. Блажевич, О.Е. Смирнова, В.М. Кирилина, П.М. Маслюков</copyright-statement><copyright-year>2023</copyright-year><copyright-holder xml:lang="en">Л.Е. Блажевич, О.Е. Смирнова, В.М. Кирилина, П.М. Маслюков</copyright-holder><copyright-holder xml:lang="ru">Л.Е. Блажевич, О.Е. Смирнова, В.М. Кирилина, П.М. Маслюков</copyright-holder></permissions><self-uri xlink:href="https://transsyst.ru/0869-8139/article/view/651582">https://transsyst.ru/0869-8139/article/view/651582</self-uri><abstract xml:lang="en"><p id="idm45181324133584">This article presents the results of studies of the levels of expression of the <italic>IL13R</italic> gene and the levels of expression of the molecular IL13R in the bronchi of control rats and rats with ovalbumin-induced asthma. The choice of these receptors is due to the great importance of these structures in the pathogenesis of allergic bronchial asthma. Biological materials of 64 Wistar rats were studied using real-time PCR and immunohistochemical methods. As a result of the studies, it was found that under conditions of asthma development in the tissues of the bronchi of rats, a pronounced expression of the <italic>IL13R</italic> genes, a significant expression of the molecular receptor for interleukin-13, occurs. In bronchi with an intramural ganglion (bifurcation zone), the level of <italic>IL13R</italic> gene expression and the level of expression of the IL13R molecular receptor were significantly higher than in tracheal samples without ganglia. Sodium cromoglycate, administered to rats 5 hours after the last inhalation of ovalbumin, led to a decrease in the mRNA content in the bronchi of animals compared to animals that did not receive mast cell stabilizer treatment.</p></abstract><trans-abstract xml:lang="ru"><p id="idm45181324133296">В статье представлены результаты исследований уровней экспрессии гена рецепторов интерлейкина-13 (IL-13R) и уровней экспрессии IL-13R в бронхах контрольных крыс и крыс с овальбумин-индуцированной астмой. Выбор этих рецепторов обусловлен большим значением данных структур в патогенезе аллергической бронхиальной астмы. Были исследованы биологические материалы 64 крыс линии Вистар при помощи метода ПЦР в режиме реального времени и иммуногистохимическим методом. Установлено, что в условиях развития астмы в тканях бронхов крыс происходит выраженная экспрессия генов <italic>IL13R</italic>, значительная экспрессия рецептора к IL-13. В участках бронхов, содержащих интрамуральные ганглии (область бифуркации), уровень экспрессии генов <italic>IL13R</italic> и уровень экспрессии рецептора IL-13R были значительно выше, чем в образцах трахеи без ганглиев. Кромогликат натрия, введенный в организм крыс через 5 ч после последней ингаляции овальбумином, приводил к снижению содержания мРНК в бронхах животных по сравнению с животными, не получавшими обработку стабилизатором тучных клеток.</p></trans-abstract><kwd-group xml:lang="en"><kwd>: interleukin-13</kwd><kwd>model of ovalbumin-induced bronchial asthma</kwd><kwd>intramural ganglion</kwd><kwd>sodium cromoglycate</kwd></kwd-group><kwd-group xml:lang="ru"><kwd>интерлейкин-13</kwd><kwd>модель овальбумин-индуцированной бронхиальной астмы</kwd><kwd>рецептор</kwd><kwd>интрамуральный ганглий</kwd><kwd>кромогликат натрия</kwd></kwd-group></article-meta></front><body></body><back><ref-list><ref id="B1"><label>1.</label><mixed-citation>Nikolskii AA, Shilovskiy IP, Barvinskaia ED, Korneev AV, Sundukova MS, Khaitov MR (2021) Role of STAT3 Transcription Factor in Pathogenesis of Bronchial Asthma. Biochemistry (Mosc) 86(11): 1489–1501. https://doi.org/10.1134/S0006297921110122</mixed-citation></ref><ref id="B2"><label>2.</label><mixed-citation>Duan W, Aguinaldo AM, Leung BP, Vlahos CJ, Wong WS (2005) An anti-inflammatory role for a phosphoinositide 3-kinase inhibitor LY294002 in a mouse asthma model. Int Immunopharmacol J 5: 495–502. https://doi.org/10.1016/j.intimp.2004.10.015</mixed-citation></ref><ref id="B3"><label>3.</label><mixed-citation>Marone G, Granata F, Pucino V, Pecoraro A, Heffler E, Loffredo S, Scadding GW, Varricchi G (2019) The Intriguing Role of Interleukin 13 in the Pathophysiology of Asthma. Front Pharmacol 10: 1387. https://doi.org/10.3389/fphar.2019.01387</mixed-citation></ref><ref id="B4"><label>4.</label><mixed-citation>Eum SY, Maghni K, Tolloczko B, Eidelman DH, Martin JG (2005) IL-13 may mediate allergen-induced hyperresponsiveness independently of IL-5 or eotaxin by effects on airway smooth muscle. Am Physiol Lung Cell Mol Physiol J 288: 576–584. https://doi: 10.1152 /ajplung.00380.2003</mixed-citation></ref><ref id="B5"><label>5.</label><mixed-citation>Harb H, Chatila Talal A (2019) Mechanisms of Dupilumab. Clin Exp Allergy 50(1): 5–14. https://doi.org/10.1111/cea.13491</mixed-citation></ref><ref id="B6"><label>6.</label><mixed-citation>Moran A, Pavord ID (2020) Anti-IL-4/IL-13 for the treatment of asthma: the story so far. Expert Opin Biol Ther 20(3): 283–294. https://doi.org/10.1080/14712598.2020.1714027</mixed-citation></ref><ref id="B7"><label>7.</label><mixed-citation>Hammad H, Lambrecht BN (2021) The basic immunology of asthma. Cell Epub 184(6): 1469–1485. https://doi.org/10.1016/j.cell.2021.02.016</mixed-citation></ref><ref id="B8"><label>8.</label><mixed-citation>Lentsch AB, Czermak BJ, Jordan JA, Ward PA (1999) Regulation of acute lung injury by endogenous IL-13. J Immunol 162: 1071–1076. PMID: 9916735</mixed-citation></ref><ref id="B9"><label>9.</label><mixed-citation>Amin K, Janson C, Boman G, Venge P (2005) The extracellular deposition of mast cell products is increased in hypertrophic airways smooth muscles in allergic asthma but not in nonallergic asthma. Allergy J 60: 1241–1247. https://doi: 10.1111 / j.1398-9995.2005.00823.x</mixed-citation></ref><ref id="B10"><label>10.</label><mixed-citation>Munitz A, Brandt EB, Mingler M, Finkelman FD, Rothenberg ME (2008) Different roles of IL-13 and IL-4 via IL-13 alpha1 receptor and L-4 type II receptor in the pathogenesis of asthma. Proc Natl Acad Sci U S A 105: 7240–7245. https://doi.org/10.1073/pnas.0802465105</mixed-citation></ref><ref id="B11"><label>11.</label><mixed-citation>Hershey GK (2003) IL-13 receptors and signaling pathways: an evolving web. J Allergy Clin Immunol 111: 677–690. https://doi.org/10.1067/mai.2003.1333</mixed-citation></ref><ref id="B12"><label>12.</label><mixed-citation>Bhattacharjee A, Shukla M, Yakubenko VP, Mulya A, Kundu S, Cathcart MK (2013) IL-4 and IL-13 employ discrete signaling pathways for target gene expression in alternatively activated monocytes/macrophages. Free Radic Biol Med 54: 1–16. https://doi.org/10.1016/j.freeradbiomed.2012.10.553</mixed-citation></ref><ref id="B13"><label>13.</label><mixed-citation>Kuperman DA, Huang X, Koth LL, Chang GH, Dolganov GM, Zhu Z (2002) Direct effects of interleukin-13 on epithelial cells cause airway hyperreactivity and mucus overproduction in asthma. Nat Med 8: 885–889. https://doi.org/10.1038/nm734</mixed-citation></ref><ref id="B14"><label>14.</label><mixed-citation>Cao H, Zhang J, Liu H, Wan L, Zhang H, Huang Q (2016) IL-13/STAT6 signaling plays a critical role in the epithelial-mesenchymal transition of colorectal cancer cells. Oncotarget 7: 61183–61198.https://doi.org/10.18632/oncotarget.11282</mixed-citation></ref><ref id="B15"><label>15.</label><mixed-citation>Wang IM, Lin H, Goldman SJ, Kobayashi M (2004) STAT-1 is activated by IL-4 and IL-13 in multiple cell types. Mol Immunol 41: 873–884. https://doi.org/10.1016/j.molimm.2004.04.027</mixed-citation></ref><ref id="B16"><label>16.</label><mixed-citation>Pham TH, Bak Y, Oh JW, Hong J, Lee S, Hong JT (2019) Inhibition of IL-13 and IL-13Ralpha2 Expression by IL-32theta in Human Monocytic Cells Requires PKCdelta and STAT3. Associat Int J Mol Sci 20: 19–49. https://doi.org/10.3390/ijms20081949</mixed-citation></ref><ref id="B17"><label>17.</label><mixed-citation>Chen W, Sivaprasad U, Tabata Y, Gibson AM, Stier MT, Finkelman FD (2009) IL-13R alpha 2 membrane and soluble isoforms differ in humans and mice. J Immunol 183: 7870–7876. https://doi.org/10.4049/jimmunol.0901028</mixed-citation></ref><ref id="B18"><label>18.</label><mixed-citation>Chen W, Sivaprasad U, Gibson AM, Ericksen MB, Cunningham CM, Bass SA (2013) IL-13 receptor alpha2 contributes to development of experimental allergic asthma. J Allergy Clin Immunol 132: 951–958. https://doi.org/10.1016/j.jaci.2013.04.016</mixed-citation></ref><ref id="B19"><label>19.</label><mixed-citation>Ingram JL, Kraft M (2012) IL-13 in asthma and allergic disease: asthma phenotypes and targeted therapies. J Allergy Clin Immunol 130: 829–842. https://doi.org/10.1016/j.jaci.2012.06.034</mixed-citation></ref><ref id="B20"><label>20.</label><mixed-citation>Lupardus PJ, Birnbaum ME, Garcia KC (2010) Molecular basis for hared cytokine recognition revealed in the structure of an unusually high ffinity complex between IL-13 and IL-13Ralpha2. Structure 18: 332–342. https://doi.org/10.1016/j.str.2010.01.003</mixed-citation></ref><ref id="B21"><label>21.</label><mixed-citation>Kasaian MT, Raible D, Marquette K, Cook TA, Zhou S, Tan XY (2011) IL-13 antibodies influence IL-13 clearance in humans by modulating scavenger activity of IL-13Ralpha2. J Immunol 187: 561–569. https://doi.org/10.4049/jimmunol.1100467</mixed-citation></ref><ref id="B22"><label>22.</label><mixed-citation>Fichtner-Feigl S, Strober W, Kawakami K, Puri RK, Kitani A (2006) IL-13 signaling through the IL-13alpha2 receptor is involved in induction of TGF-beta1 production and fibrosis. Nat Med 12: 99–106. https://doi.org/10.1038/nm1332</mixed-citation></ref><ref id="B23"><label>23.</label><mixed-citation>Fujisawa T, Joshi B, Nakajima A, Puri RK (2009) A novel role of interleukin-13 receptor alpha2 in pancreatic cancer invasion and metastasis. Cancer Res 69: 8678–8685. https://doi.org/10.1158/0008-5472.CAN-09-2100</mixed-citation></ref><ref id="B24"><label>24.</label><mixed-citation>ГОСТ 33215-2014 Руководство по содержанию и уходу за лабораторными животными. Правила оборудования помещений и организации процедур от 01.07.2016. [GOST 33215-2014 Guidelines for the maintenance and care of laboratory animals. Rules for equipping premises and organizing procedures dated 01.07.2016. (In Russ)].</mixed-citation></ref><ref id="B25"><label>25.</label><mixed-citation>Close B, Banister K, Baumans V, Warwick C (1997) Recommendations for euthanasia of experimental animals. Part 2 DGXT of the Eur Commission Lab Animals J 31: 1–32. https://doi.org/10.1258/002367797780600297</mixed-citation></ref><ref id="B26"><label>26.</label><mixed-citation>Masakazu Y, Osamu S, Kenji N, Tetsuji M, Koji S (2006) Propofol Attenuates Ovalbumin-Induced Smooth Muscle Contraction of the Sensitized Rat Trachea: Inhibition of Serotonergic and Cholinergic Signaling. Anesthesia &amp; Analgesia J 3: 594–600.</mixed-citation></ref><ref id="B27"><label>27.</label><mixed-citation>Akin Yilmaz, Hacer Ilke Onen, Ebru Alp, Sevda Menevse (2012) Real-Time PCR for Gene Expression Analysis. INTECH 12: 229–254. https://doi.org/10.5772/37356</mixed-citation></ref><ref id="B28"><label>28.</label><mixed-citation>Masuda N, Mantani Y, Yoshitomi C, Yuasa H, Nishida M, Aral M, KawanoJ, Yokoyama T, Hoshi N, Kitagawa H (2018) Immunohistochemical study on the secretory host defense system with lysozyme and secretory phospholipase A2 throughout rat respiratory tract. J Vet Med Sci 80(2): 323–332. https://doi.org/10.1292/jvms.17-0503</mixed-citation></ref><ref id="B29"><label>29.</label><mixed-citation>Bochner BS, Klunk DA, Sterbinsky SA, Coffman RL, Schleimer RP (1995) IL-13 selectively induces expression of the vascular cell adhesion molecule-1 in human endothelial cells. J Immunol 154: 799–803.</mixed-citation></ref><ref id="B30"><label>30.</label><mixed-citation>Oetjen LK, Mack MR, Feng J, Whelan TM, Niu H, Guo CJ (2017) Sensory neurons co-opt classical immune signaling pathways to mediate chronic pruritus. Cell 171: 217–228. https://doi.org/10.1016/j.cell.2017.08.006</mixed-citation></ref><ref id="B31"><label>31.</label><mixed-citation>Трулев АС, Кудрявцев ИВ, Назаров ПГ (2012) Факторы острой фазы воспаления как модуляторы взаимодействия тучных клеток и фибробластов. Бюл ВСНЦ СО РАМН 85(3): 319–322. [Trulev AS, Kudryavtsev IV, Nazarov PG (2012) Factors of the acute phase of inflammation as modulators of the interaction between mast cells and fibroblasts. Bull VSNC SO RAMS 85(3): 319–322. (In Russ)].</mixed-citation></ref></ref-list></back></article>
